Ongoing clinical trials for patients with RMC and RCCU-MP:
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (REPRINT)